Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Male pattern baldness may predict prostate cancer risk.

The study aims to understand how mood, physical activity, light exposure, and seasonal changes affect sleep patterns.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Testosterone may influence COVID-19 severity and outcomes.

Skin reactions from cancer treatments might predict how well the treatments work.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Botulinum toxin is not effective or cost-efficient for treating male pattern baldness.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The document doesn't provide enough information to summarize.

PRFM may help treat hair loss, especially in mild cases.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Skin can become dry and thick in hypothyroidism.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

COVID-19 can cause temporary hair loss.